Literature DB >> 25416317

Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Rami E Saade1, Ehab Y Hanna, Diana Bell.   

Abstract

Esthesioneuroblastoma is a sinonasal tumor with distinct clinicopathologic features, multiple facets, and a spectrum of behavior. Characterization of this disease is challenging, and clinically, several staging systems have been used with no consensus on a single scheme. Recently, the Hyams histological grading system has emerged as a promising prognostication tool that offers an added value to stage. This review addresses prognosis and biology in esthesioneuroblastoma. More specifically, we sought to present a critical appraisal on the value of each of these stratification systems, stage vs. grade, in identifying risk groups and guiding management.

Entities:  

Mesh：

Year:  2015        PMID： 25416317     DOI： 10.1007/s11912-014-0423-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  25 in total

Review 1.  Misdiagnosis of olfactory neuroblastoma.

Authors:  Zvi R Cohen; Eric Marmor; Gregory N Fuller; Franco DeMonte
Journal:  Neurosurg Focus       Date:  2002-05-15       Impact factor: 4.047

2.  Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.

Authors:  Daniel Jethanamest; Luc G Morris; Andrew G Sikora; David I Kutler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-03

Review 3.  Esthesioneuroblastoma: a meta-analysis and review.

Authors:  P Dulguerov; A S Allal; T C Calcaterra
Journal:  Lancet Oncol       Date:  2001-11       Impact factor: 41.316

4.  Esthesioneuroblastoma: prognosis and management.

Authors:  A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

5.  Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival.

Authors:  Jeong-Whun Kim; Il Gyu Kong; Chul Hee Lee; Dong Young Kim; Chae-Seo Rhee; Yang-Gi Min; Chul Woo Kim; Jin-Haeng Chung
Journal:  Otolaryngol Head Neck Surg       Date:  2008-11       Impact factor: 3.497

6.  Esthesioneuroblastoma: 25-year experience at a single institution.

Authors:  Mark E Zafereo; Samer Fakhri; Richard Prayson; Pete S Batra; Joung Lee; Donald C Lanza; Martin J Citardi
Journal:  Otolaryngol Head Neck Surg       Date:  2008-04       Impact factor: 3.497

7.  Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.

Authors:  Gabriel G Malouf; Odile Casiraghi; Eric Deutsch; Joel Guigay; Stéphane Temam; Jean Bourhis
Journal:  Eur J Cancer       Date:  2013-01-10       Impact factor: 9.162

8.  Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma.

Authors:  Marc Diensthuber; Marc Potinius; Thomas Rodt; Alexandru C Stan; Hans-J Welkoborsky; Madjid Samii; Jonas Schreyögg; Thomas Lenarz; Timo Stöver
Journal:  J Neurooncol       Date:  2008-04-23       Impact factor: 4.130

9.  Clincopathological analysis of olfactory neuroblastoma.

Authors:  Shintaro Fukushima; Yasuo Sugita; Daisuke Niino; Hiroyuki Mihashi; Koichi Ohshima
Journal:  Brain Tumor Pathol       Date:  2012-02-14       Impact factor: 3.298

10.  Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.

Authors:  H F Frierson; S E Mills; R E Fechner; J B Taxy; P A Levine
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394
View more
  17 in total

Review 1.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

Review 2.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 4.  Olfactory Neuroblastoma.

Authors:  Ahmed S Abdelmeguid
Journal:  Curr Oncol Rep       Date:  2018-02-07       Impact factor: 5.075

Review 5.  Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.

Authors:  Khodayar Goshtasbi; Arash Abiri; Mehdi Abouzari; Ronald Sahyouni; Beverly Y Wang; Bobby A Tajudeen; Frank P K Hsu; Gilbert Cadena; Edward C Kuan
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-28       Impact factor: 3.858

6.  Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Authors:  Matt Lechner; Yoko Takahashi; Mario Turri-Zanoni; Jacklyn Liu; Nicholas Counsell; Mario Hermsen; Raman Preet Kaur; Tianna Zhao; Murugappan Ramanathan; Volker H Schartinger; Oscar Emanuel; Sam Helman; Jordan Varghese; Jozsef Dudas; Herbert Riechelmann; Susanne Sprung; Johannes Haybaeck; David Howard; Nils Wolfgang Engel; Sarah Stewart; Laura Brooks; Jessica C Pickles; Thomas S Jacques; Tim R Fenton; Luke Williams; Francis M Vaz; Paul O'Flynn; Paul Stimpson; Simon Wang; S Alam Hannan; Samit Unadkat; Jonathan Hughes; Raghav Dwivedi; Cillian T Forde; Premjit Randhawa; Simon Gane; Jonathan Joseph; Peter J Andrews; Gary Royle; Alessandro Franchi; Roberta Maragliano; Simonetta Battocchio; Helen Bewicke-Copley; Christodoulos Pipinikas; Amy Webster; Chrissie Thirlwell; Debbie Ho; Andrew Teschendorff; Tianyu Zhu; Christopher D Steele; Nischalan Pillay; Bart Vanhaesebroeck; Ahmed Mohyeldin; Juan Fernandez-Miranda; Ki Wan Park; Quynh-Thu Le; Robert B West; Rami Saade; R Peter Manes; Sacit Bulent Omay; Eugenia M Vining; Benjamin L Judson; Wendell G Yarbrough; Maddalena Sansovini; Nicolini Silvia; Ilaria Grassi; Alberto Bongiovanni; David Capper; Ulrich Schüller; Selvam Thavaraj; Ann Sandison; Pavol Surda; Claire Hopkins; Marco Ferrari; Davide Mattavelli; Vittorio Rampinelli; Fabio Facchetti; Piero Nicolai; Paolo Bossi; Oswaldo A Henriquez; Kelly Magliocca; C Arturo Solares; Sarah K Wise; Jose L Llorente; Zara M Patel; Jayakar V Nayak; Peter H Hwang; Peter D Lacy; Robbie Woods; James P O'Neill; Amrita Jay; Dawn Carnell; Martin D Forster; Masaru Ishii; Nyall R London; Diana M Bell; Gary L Gallia; Paolo Castelnuovo; Stefano Severi; Valerie J Lund; Ehab Y Hanna
Journal:  Eur J Cancer       Date:  2021-12-31       Impact factor: 10.002

Review 7.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

8.  Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

Authors:  Robbie S R Woods; Thavakumar Subramaniam; Mary Leader; Rory McConn-Walsh; James Paul O'Neill; Peter D Lacy
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-01

9.  Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.

Authors:  Luyao Zhang; Kai Niu; Kang Zhu; Cui Xia; Jing Yan; Wei Zhao; Junrong Wei; Maoli Duan; Guoxi Zheng
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

10.  An Uncommon Case of Pediatric Esthesioneuroblastoma Presenting as SIADH: 18F-FDG PET/CT in Staging and Post-Therapeutic Assessment.

Authors:  Marie Øbro Fosbøl; Anders Bilde; Jeppe Friborg; Eric von Benzon; Andreas Kjær; Christian von Buchwald; Lise Borgwardt
Journal:  Diagnostics (Basel)       Date:  2018-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.